CopyMark Law Group
4.9/5
Drawing for CANNSYNTHESIS

USPTO serial 87222176

CANNSYNTHESIS

Reviewed by CopyMark Law Group

Reg. 5487407Status 710
Filing date
Status date
Registration date
Jun 5, 2018
Examiner
CARROLL, DORITT
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with CANNSYNTHESIS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Trademark Monitoring
(312) 319-4460
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Start a new application
(312) 319-4460

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Michael B. Lasky

MICHAEL B. LASKY SCHWEGMAN LUNDBERG WOESSNERP.O. BOX 2938MINNEAPOLIS, MN 55402UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical and biopharmaceutical drugs for the treatment of pain, inflammation, cancer, seizures, and epilepsySECTION 8 - CANCELLEDMar 1, 2018
040Custom manufacture of pharmaceuticals and biopharmaceutical drugs; Custom manufacturing of new biological products for others; Custom manufacture of chemical products for others; Custom manufacture of nutraceuticals for others; Custom manufacture of cosmeceuticals for others; Custom manufacture of medical veterinary products for others; research in the field of manufacturing processesSECTION 8 - CANCELLEDMar 1, 2018
042Research and development of pharmaceuticals and biopharmaceutical drugs; Medical research and development in the field of synthetic biology, molecular biology, genetic engineering, and organic chemistry; Research and development of new biological products for others; Research and development of new chemical products for others; New product research, namely, nutraceutical research and development for others; New product research, namely, cosmeceutical research and development for others; Veterinary medical research and development for others; New product research, namely, research and development in the field of bioinformatics and proteomicsSECTION 8 - CANCELLEDMar 1, 2018

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Dec 20, 2024C8..CANCELLED SEC. 8 (6-YR)—
Jun 5, 2023REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Jun 5, 2018R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
May 3, 2018SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
May 2, 2018CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Apr 12, 2018SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Apr 4, 2018AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Mar 19, 2018IUAFUSE AMENDMENT FILED—
Mar 19, 2018EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Nov 23, 2017EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Nov 21, 2017EX1GSOU EXTENSION 1 GRANTED—
Nov 21, 2017EXT1SOU EXTENSION 1 FILED—
Nov 21, 2017EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 23, 2017NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Mar 28, 2017NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Mar 28, 2017PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 22, 2017EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS—
Mar 8, 2017NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Feb 14, 2017CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 14, 2017XAECEXAMINER'S AMENDMENT ENTERED—
Feb 14, 2017GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Feb 14, 2017GNEAEXAMINERS AMENDMENT E-MAILED—
Feb 14, 2017CNEAEXAMINERS AMENDMENT -WRITTEN—
Feb 8, 2017DOCKASSIGNED TO EXAMINER—
Nov 4, 2016NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 4, 2016NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance